Cancer-Related Molecular Mechanisms Research
707 researchers across 16 institutions
Scientists investigate the fundamental molecular processes that drive cancer development, progression, and response to therapy. Research focuses on understanding how genetic mutations, epigenetic alterations, and cellular signaling pathways contribute to uncontrolled cell growth and metastasis. Investigations employ a range of molecular biology techniques, including genomics, proteomics, and advanced imaging, to identify key molecular targets and mechanisms underlying various cancer types. This work also explores how the tumor microenvironment and immune system interactions influence cancer biology and treatment efficacy.
This research holds particular relevance for Arkansas, a state with a significant burden of certain cancers. Understanding cancer-related molecular mechanisms can inform public health strategies and the development of targeted interventions to address disparities in cancer incidence and outcomes observed within the state's population. Furthermore, insights gained can contribute to the growth of the state's bioscience and biotechnology sectors, fostering innovation in diagnostics and therapeutics.
This area of study inherently connects to disciplines such as disease mechanisms, immune response, metabolism, and pharmacology. Research is conducted across multiple Arkansas institutions, fostering a broad base of expertise and collaboration.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Bart Barlogie | UAMS | 138 | 76,541 | High Impact | |
| Andrew N. J. McKenzie | University of Arkansas | 113 | 46,436 | High Impact | |
| Guido Tricot | UAMS | 97 | 36,409 | High Impact | |
| Jian‐Min Yuan | University of Arkansas | 95 | 37,763 | High Impact | |
| Thomas J. Kelly | UAMS | 90 | 29,658 | High Impact | |
| John D. Shaughnessy | UAMS | 88 | 31,240 | High Impact | |
| David M. Parham | UAMS | 81 | 21,213 | High Impact | |
| Jingyi Chen | University of Arkansas | 80 | 34,255 | ARA Grant PI High Impact | |
| Andrew Morris | UAMS | 77 | 22,261 | ||
| Igor P. Pogribny | NCTR | 76 | 18,075 | ARA High Impact | |
| Thomas M. Badger | UAMS | 71 | 15,633 | High Impact | |
| Maurizio Zangari | UAMS | 71 | 19,446 | High Impact | |
| Fenghuang Zhan | UAMS | 67 | 19,235 | Grant PI High Impact | |
| W. Sue T. Griffin | UAMS | 66 | 17,576 | Grant PI High Impact | |
| Charles A. O’Brien | UAMS | 64 | 17,720 | Grant PI High Impact | |
| Shiv Srivastava | UAMS | 64 | 15,057 | High Impact | |
| Naveena Singh | University of Arkansas – Fort Smith | 64 | 16,943 | High Impact | |
| Luke R. Howard | University of Arkansas | 58 | 13,911 | High Impact Grants | |
| Frank A. Simmen | UAMS | 55 | 7,681 | High Impact | |
| Stepan Melnyk | UAMS | 55 | 10,973 | High Impact |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 2,426
- 2 The University of Texas MD Anderson Cancer Center 2,129
- 3 National Institutes of Health 1,287
- 4 Johns Hopkins University 1,277
- 5 Stanford University 1,192
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Cancer-Related Molecular Mechanisms Research.